AI That Fits the Clinical Workflow: Interview with Anumana CEO Maulik Nanavaty

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/d5/60/7a/d5607a7e-117a-0344-e05f-653d19125116/mza_2005314729548216763.jpg/600x600bb.jpg

Medsider: Learn from Medtech and Healthtech Founders and CEOs

Scott Nelson

220 episodes

1 week ago

Learn from the brightest CEOs in medtech and healthtech. That's our primary goal with Medsider. We unpack the strategies, tactics, and secrets behind the most successful startups. Join tens of thousands of ambitious doers and get access to the top medical device and health technology thought leaders.

All content for Medsider: Learn from Medtech and Healthtech Founders and CEOs is the property of Scott Nelson and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Entrepreneurship

Business,

Management

https://img.transistor.fm/8ZLWmwBNTlSHibmM_R69Wfehk3wOPlwwtuNz6LqPXy8/rs:fill:3000:3000:1/q:60/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8yOWQz/NDVlYTcwNTM1YzI3/MzRhOGYzOTA2N2Qz/ZThlYi5qcGc.jpg

AI That Fits the Clinical Workflow: Interview with Anumana CEO Maulik Nanavaty

Medsider: Learn from Medtech and Healthtech Founders and CEOs

48 minutes

3 months ago

AI That Fits the Clinical Workflow: Interview with Anumana CEO Maulik Nanavaty

In this episode of Medsider Radio, we sat down with Maulik Nanavaty, CEO of Anumana.

Anumana, an AI-driven health technology company focused on cardiovascular care, is taking a pragmatic approach to scaling AI in medicine.

Maulik is a seasoned healthcare executive with over 30 years of global experience in the medical device industry. He spent 18 years at Boston Scientific, where he led its $1B+ Neuromodulation division and served as President of Boston Scientific Japan. Prior to that, he held leadership positions at Baxter. Known for driving innovation in implantable and artificial intelligence (AI)-powered technologies, Maulik also serves on the board of Rani Therapeutics.

In this interview, Maulik shares why building a strong risk-benefit case and designing around real-world clinician needs are key to adoption. With data from over 20 million patients and a focus on transparency, Anumana is reshaping how AI reaches the point of care.

Before we dive into the discussion, I wanted to mention a few things:

First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.

Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!

We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!

In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, if you'd rather read than listen, here's a link to the full interview with Maulik Nanavaty.